Boxplot analyses revealed that MELK, BIRC5, and CEACAM6 were significantly overexpressed in HR+/HER2– breast cancer tissues compared to normal breast tissues in the TCGA cohort, whereas RARRES1 expression was markedly reduced in tumor tissues (p < 0.001; Figure 5A). This evidence concerns the gene BIRC5 and breast cancer.